A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes (original) (raw)
References
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automatic Control19: 716–726 Article Google Scholar
Antoniou AC, Gayther SA, Stratton JF, Ponder BAJ, Easton DF (2000) Risk models for familial ovarian and breast cancer. Genet Epidemiol18: 173–190 ArticleCASPubMed Google Scholar
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton DF (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol21: 1–18 ArticleCASPubMed Google Scholar
Claus EB, Risch N, Thompson D (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet48: 232–242 CASPubMedPubMed Central Google Scholar
Cox DR, Oakes D (1984) Analysis of survival data. London: Chapman and Hall
Cui J, Antoniou AC, Dite GS, Southey MC, Venter D, Easton DF, Giles GG, McCredie MRE, Hopper JL (2001) After BRCA1 and BRCA2 – what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet68: 420–431 ArticleCASPubMed Google Scholar
Dunning AM, Healy CS, Pharoah PDP, Foster NA, Lipscompe JM, Redman KL, Easton DF, Day DF, Ponder BAJ (1998) No association between a polymorphism in the steroid metabolism gene CYP17 and the risk of breast cancer. Br J Cancer77: 2045–2047 ArticleCASPubMedPubMed Central Google Scholar
Easton DF, Bishop DT, Ford D, Crockford GP and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer. Am J Hum Genet52: 678–701 CASPubMedPubMed Central Google Scholar
Easton DF, Ford D, Bishop T and the Breast Cancer Linkage Consortium (1995) Breast and Ovarian Cancer incidence in BRCA1 mutation carriers. Am J Hum Genet56: 265–271 ArticleCASPubMedPubMed Central Google Scholar
Elston RC (1990) Models for discrimination between alternative models of inheritance. In Advances in statistical methods for generic livestock Gianola D and Hammond F (eds) pp 41–45, New York: Springer Berlin, Heidelberg Chapter Google Scholar
Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contributions to breast and ovarian cancer incidence. Am J Hum Genet57: 1457–1462 CASPubMedPubMed Central Google Scholar
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Cayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet62: 676–689 ArticleCASPubMedPubMed Central Google Scholar
Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MRE, Easton DF, Venter DJ and the Australian Breast Cancer Family Study (1999) Population-based estimate of the average age specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev8: 741–747 CASPubMed Google Scholar
Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N (1993) An association between the risk of cancer and mutations in the HRAS1 minisatelite locus. N Engl J Med329: 517–523 ArticleCASPubMed Google Scholar
Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Easton DF (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst90: 1138–1145 ArticleCASPubMed Google Scholar
Lange K, Weeks D (1988) Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol5: 471–472 ArticleCASPubMed Google Scholar
Lange K (1997b) Mathematical and Statistical methods for genetic analysis. New York, Berlin, Heidelberg: Springer-verlang Book Google Scholar
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer sarcomas and other neoplasms. Science250: 1233–1238 ArticleCASPubMed Google Scholar
Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MMM, Easton DF, Eeles RA, Hodgson S, Mulvihill JJ, Murday VA, Tucker MA, Mariman ECM, Starink TM, Ponder BAJ, Ropers HH, Kremer H, Longy M, Eng C (1996) Localisation of the gene for Cowden disease to chromosome 10q22-23. Nat Genet13: 114–114 ArticleCASPubMed Google Scholar
Olsen JH, Hahnemann JM, Borresen-Dale A, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD, Tucker M (2001) Cancer in Patients with Ataxia-Talangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst93: 121–127 ArticleCASPubMed Google Scholar
Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Hum Genet62: 145–158 ArticleCASPubMedPubMed Central Google Scholar
Pharoah PP, Day NE, Duffy S, Easton DF, Ponder BAJ (1997) Family history and the risk of breast cancer: A systematic review and meta analysis. Int J Cancer71: 800–809 ArticleCASPubMed Google Scholar
Rebbeck T, Kantof P, Krithivas K, Neuhausen A, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown MA (1999a) Modification of breast cancer risk in BRCA1 mutation carriers by the AIB1 gene. Carcinogenesis40: 194 Google Scholar
Rebbeck TR, Kantof PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MAB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M (1999b) Modification of BRCA1-associated breast cancer risk by the polymorphic Androgen-Receptor CAG repeat. Am J Hum Genet64: 1371–1377 ArticleCASPubMedPubMed Central Google Scholar
Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med336: 1401–1408 ArticleCASPubMed Google Scholar
Swift M, Morell D, Massey R, Chase CL (1991) Incidence of cancer in 161 families affected by Ataxia-Talangiectasia. N Engl J Med325: 1831–1836 ArticleCASPubMed Google Scholar
The Anglian Breast Cancer Study Group (2000) Prevalence and Penetrance of BRCA1 and BRCA2 mutations in a large population based series of breast cancer cases. Br J Cancer83: 1301–1308
Thompson D, Easton DF on behalf of the Breast Cancer Linkage Consortium (2001) Variation in cancer risks by mutation position in BRCA2 mutation carriers. Am J Hum Genet68: 410–419 ArticleCASPubMedPubMed Central Google Scholar
Whittemore AS, Gong G, Intyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet60: 496–504 CASPubMedPubMed Central Google Scholar